• FDA Panel Opposes Approving Cipro DPI to Treat Non-CF Bronchiectasis
  • Bronchiectasis More Prevalent in US Than Previously Thought, Study Finds
  • Pilot Study to Test Nitric Oxide Gas Treatment on Nontuberculous Mycobacteria Infections
  • Children’s National, NORD Partner to Create Rare Disease ‘Centers of Excellence’
  • Three Factors Raise Risk of Bronchiectasis Patients Developing Drug-resistant Infections, Study Suggests
  • Sleep Disorders Common Among Non-Cystic Fibrosis Bronchiectasis Patients, Study Finds
  • #NORDsummit – Alternatives to Large Placebo Trials, Grant Awards Among Ways FDA Supporting Rare Diseases, Chief Says
  • #NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says
  • Polyphor Launches Development of Inhaled Antibiotic for Respiratory Diseases
  • Untreated Patients with Nodular Bronchiectatic MAC Lung Disease Fare Poorly Over Time, Study Finds
  • Spanish Study Identifies Hospitalization Risk Factors Among Bronchiectasis Patients
  • FDA Accepts Aradigm’s New Drug Application for Linhaliq to Treat Non-CF Bronchiectasis